New creatine trial listing offers design, not results

Key Takeaways

• This ClinicalTrials.gov entry is a trial registration, not a published results paper.
• The source describes four visits over about 56 days, with diet records, body measurements and handgrip testing.
• Because no outcome data are posted, no claims can be made yet about soy protein, creatine or their combination.
• The practical creatine take-away still comes from broader evidence: monohydrate remains the best-studied form.
• For most adults using creatine, mainstream evidence supports 3 to 5 g/day maintenance, with loading optional.

What this new listing actually shows

The news here is modest but still useful: a new ClinicalTrials.gov registration describes a study on soy protein and creatine supplementation in men performing resistance exercise, but it does not provide results. That distinction matters. Trial registrations can tell readers what researchers planned to measure and roughly how the study was structured, yet they are not the same thing as a peer-reviewed paper reporting final data.

Based on the source material, participants attend four visits. At the first visit, they provide consent and receive a three-day dietary intake form. Three days later, at visit two, those diet records are collected and participants receive diet programmes and supplements. The third visit occurs 53 days after the second, when another three-day dietary record is issued to assess dietary compliance. Three days after that, at the final visit, researchers collect the diet records and perform BIA, skinfold-thickness assessments, body-circumference measurements and handgrip strength testing.

In plain language, this appears to be an intervention lasting about 56 days from supplement distribution to final testing. What it does not tell us is the most important part for consumers: whether creatine improved strength, body composition or anything else. Until outcome data are posted or published, the correct headline is simply that a creatine study is underway or registered, not that creatine "worked" in this trial.

How the study seems to be designed

Even without results, the trial record gives clues about the study design. The intervention appears to involve adult men who perform resistance exercise, and the researchers plan to monitor several practical outcomes:

• Dietary intake compliance via repeated three-day food records
• Body composition-related measures using BIA and skinfold thickness
• Anthropometrics through body-circumference measurements
• Strength via handgrip testing

That combination is common in smaller exercise-nutrition studies because it is relatively easy to administer in a university or clinic setting. It can generate useful signals, especially when researchers want to know whether a supplement plan affects lean mass proxies or simple strength outcomes over several weeks.

Still, there are important unanswered questions in the registration summary provided here. The source excerpt does not state the final sample size, randomisation method, blinding, exact supplement doses, timing, training programme details, or whether there are separate soy-only, creatine-only and combination groups. Those details strongly affect how much confidence readers should place in eventual findings.

It is also worth noting that handgrip strength is a limited performance measure in the context of resistance training. Creatine is typically discussed in relation to repeated high-intensity effort, training volume and gains in lean mass over time, so handgrip alone may miss some of the ways creatine is usually expected to help.

Why no results means no conclusions yet

The biggest limitation is simple: there are no posted outcomes in the source material. That means readers should avoid three common mistakes.

1. Do not assume benefit. Creatine has strong support overall, but this specific trial has not yet shown a positive effect.
2. Do not assume equivalence. If soy protein is included, we cannot infer from the registration whether soy plus creatine matches, exceeds or falls short of any comparator.
3. Do not assume quality from topic alone. A good question does not guarantee a definitive study.

There are also measurement limitations. BIA can be influenced by hydration status, which is especially relevant in creatine research because creatine can increase intracellular water. Skinfolds and circumference measures can be informative, but they depend heavily on technician consistency. And as noted above, handgrip strength is only one narrow slice of performance.

Another issue is scope. The source says the study is in men performing resistance exercise, so even if strong results eventually appear, they would not automatically apply to women, older adults, endurance athletes or clinical populations. Readers looking for personal guidance should therefore rely on the broader evidence base, not on anticipated findings from a registration alone.

If you are comparing options now, our creatine guides, best creatine rankings and creatine brand reviews are better starting points than trying to read meaning into an unpublished registry entry.

What it means in practice for people taking creatine now

For consumers, this listing does not change current best practice. The practical advice still comes from the larger body of research, where creatine monohydrate remains the best-studied form. A typical evidence-based approach is:

• Maintenance: 3 to 5 g per day
• Optional loading: about 20 g per day split into 4 doses for 5 to 7 days, then 3 to 5 g per day
• Timing: consistency matters more than exact timing for most people

If you want a personalised estimate, use our creatine dosage calculator. If you are shopping, browse the creatine product catalog for straightforward monohydrate options.

What about combining creatine with protein, including soy protein? In principle, pairing creatine with a diet that supports training and adequate protein intake is entirely reasonable. But this registry entry does not tell us whether soy protein specifically adds something unique to creatine, whether the combination is better than either alone, or whether any observed changes would simply reflect better overall nutrition during an eight-week lifting block.

For most healthy adults, the sensible move is not to wait for this one study to decide whether creatine is worth using. The more useful question is whether your training, total diet and supplement choice align with the broader evidence. On that front, monohydrate still has the strongest case.

How this fits the existing creatine evidence

This trial registration fits into an already large literature suggesting that creatine can support high-intensity exercise performance and, over time, help people gain strength and lean mass when paired with resistance training. The strongest consensus statements continue to support creatine monohydrate as effective and generally safe for healthy individuals when used appropriately.

For example, the ISSN position stand remains one of the clearest summaries of efficacy and safety, while a later review on common questions and misconceptions about creatine helps address persistent concerns about water retention, kidneys and dosing strategies. Those papers are more useful for practical decision-making right now than an unpublished trial registry.

That broader context is exactly why disciplined reporting matters. It would be easy to overread a new listing and imply that soy protein plus creatine is the next big thing. The source does not support that. What it does support is narrower: researchers are interested enough in the question to run or register a study lasting roughly eight weeks with dietary monitoring and multiple body-composition-related measures.

So, think of this record as pipeline news, not performance proof. It signals what may soon enter the evidence base, but until data appear, it should not outweigh the long-established findings summarised in major reviews such as Antonio et al. (2021).

Bottom line

The most accurate take is straightforward: a new ClinicalTrials.gov entry describes an approximately eight-week study of soy protein and creatine in men doing resistance exercise, but no results are available yet. Because the source is a trial registration rather than a completed paper, it cannot tell us whether creatine improved handgrip strength, body composition or circumference measures in this sample.

That does not make the listing unimportant. Registered trials can preview where sports-nutrition research is headed and can help readers understand what outcomes investigators consider meaningful. But for anyone deciding whether to start creatine today, the practical answer still comes from the established literature: creatine monohydrate is the most researched option, typical maintenance intake is 3 to 5 g/day, loading is optional, and consistency matters more than chasing novelty.

We will know more only if the investigators post results or publish a full paper with group details, dosing, statistics and limitations. Until then, this is a study to watch, not a result to act on.

What this new creatine study listing tells us

• 4 study visits — Consent and diet record, supplement distribution, compliance check, final measurements
• 53 days between visits 2 and 3 — The main intervention period described in the registry excerpt
• 56 days approx. supplement phase — From supplement distribution to final testing, based on the source timeline
• 3-5 g/day mainstream creatine maintenance dose — Broader evidence-based guidance, not a dose reported in this listing

Frequently Asked Questions

Sources & Further Reading

• Kreider et al. (2017), ISSN Position Stand: Safety and Efficacy of Creatine — JISSN
• Antonio et al. (2021), Common questions and misconceptions about creatine supplementation — JISSN